Life science commercialization
Kaironexus launches commercialization firm for life-science tools and medical devices
The founder-led company will help technical teams move from product strategy through launch, partnerships, manufacturing, and commercial scale.
SAN JOSE, Calif. Kaironexus has launched a commercialization firm built for technical founders and leadership teams developing life-science tools, diagnostics, biotechnology products, and medical devices.
The company is designed to operate as the commercial team an early-stage technical organization may not yet be ready to build internally. Its work spans market and corporate strategy, launch planning, licensing and partnership development, manufacturing, supply-chain readiness, and global distribution.
Built for the gap between invention and adoption
Scientific teams can spend years proving that an instrument or platform works, then encounter a different set of constraints when it is time to define the buyer, establish pricing, prepare the field organization, scale production, or enter a new market. Kaironexus brings those workstreams together under one founder-led team.
The company brings experience from more than 25 life-science product launches and a network of more than 30,000 scientists, key opinion leaders, and industry contacts.
Cash acquisition by Sartorius after the iQue platform reached the top 15 global pharmaceutical companies.
VisionSort moved from design to manufacturing release, followed by more than $5 million in first-year revenue.
Raised across Series A through C to launch Octet and build an 11-product biosensor portfolio.
“Strategy without execution is a slide. We are here for what comes after the deck.”The Kaironexus team
Four connected commercial workstreams
Strategy and corporate advisory
Market definition, buyer strategy, commercial models, and milestone planning.Commercial strategy and launch support
Launch planning, pricing, reimbursement, channel strategy, and field readiness.Licensing and partnerships
Partner identification, evaluation, negotiation, and collaboration development.Manufacturing and supply chain
CMO and CDMO selection, scale-up readiness, and distribution relationships across the Americas, Europe, and Asia.
Founder-led from strategy through execution
Kaironexus is led by CEO Janette Phi, MBA; co-founder and Chief Commercial Officer Brett Gordon; and Business Development Director Nick Wilson, MBA.
Janette Phi, MBA
Chief Executive OfficerStrategy, commercialization, and capital across pharma and life-science tool launches.
Brett Gordon
Chief Commercial OfficerOperations, manufacturing, and global distribution through launch and scale.
Nick Wilson, MBA
Business Development DirectorLicensing, partnerships, and business development across biotech and diagnostics.
Companies preparing a first launch, building early commercial traction, expanding into new regions, or strengthening their manufacturing and partnership strategy can learn more at kaironexus.bio.
About Kaironexus
Kaironexus is a commercialization firm serving life-science tools, diagnostics, biotech, and medical-device companies. The team works with technical founders and C-level leaders from pre-seed through Series B on strategy, launches, partnerships, manufacturing, supply chains, and distribution.